Abstract
Recently, there has been a growing in alternative prevents and therapies of marine organisms for metabolic syndrome. Marine-derived bioactive peptides attracted extensive interest due to their numerous health beneficial effects including antioxidant, antihypertensive, anti-diabetes, anti-obesity. The bioactive peptides may provide novel therapeutic applications for the prevention of metabolic syndrome. The facts summarized here may provide improvement of metabolic syndrome by peptides from marine organisms. However, further insightful researches on the prevention of metabolic syndrome by marine peptides in in vivo and clinical studies are needed to firmly establish their therapeutic potency.
Keywords: Marine organisms; bioactive peptides; metabolic syndrome; cardiovascular diseases.
Current Protein & Peptide Science
Title:Marine Peptides for Preventing Metabolic Syndrome
Volume: 14 Issue: 3
Author(s): Seok-Chun Ko and You-Jin Jeon
Affiliation:
Keywords: Marine organisms; bioactive peptides; metabolic syndrome; cardiovascular diseases.
Abstract: Recently, there has been a growing in alternative prevents and therapies of marine organisms for metabolic syndrome. Marine-derived bioactive peptides attracted extensive interest due to their numerous health beneficial effects including antioxidant, antihypertensive, anti-diabetes, anti-obesity. The bioactive peptides may provide novel therapeutic applications for the prevention of metabolic syndrome. The facts summarized here may provide improvement of metabolic syndrome by peptides from marine organisms. However, further insightful researches on the prevention of metabolic syndrome by marine peptides in in vivo and clinical studies are needed to firmly establish their therapeutic potency.
Export Options
About this article
Cite this article as:
Ko Seok-Chun and Jeon You-Jin, Marine Peptides for Preventing Metabolic Syndrome, Current Protein & Peptide Science 2013; 14 (3) . https://dx.doi.org/10.2174/13892037113149990038
DOI https://dx.doi.org/10.2174/13892037113149990038 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Studies on the Transdermal Delivery of Nimodipine from a Menthol-based TTS in Human Volunteers
Current Drug Delivery The Assessment of Some Metabolic Markers by Combination of Ursolic Acid Supplementation and Resistance Training in Young Older Obese Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Diverse combination therapies of Chinese Medicine in treating Hypertension
Current Vascular Pharmacology Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design Development of a Novel Nanocomposite Based on Reduced Graphene Oxide/Chitosan/Au/ZnO and Electrochemical Sensor for Determination of Losartan
Current Analytical Chemistry Clinical Applications of Non-Antimicrobial Actions of Tetracyclines in Inflammatory Diseases
Current Drug Therapy Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
CNS & Neurological Disorders - Drug Targets Is the Vascular System a Main Target for Thyroid Hormones? From Molecular and Biochemical Findings to Clinical Perspectives
Current Vascular Pharmacology Hormone Replacement Therapy and Stroke
Current Vascular Pharmacology Urine IL-18 is a Biomarker of Early Acute Kidney Injury (AKI)
Recent Patents on Biomarkers Development of New Therapeutic Agents for Fibrodysplasia Ossificans Progressiva.
Current Molecular Medicine Drug-Induced Hypokalaemia
Current Drug Safety Inflammatory Biomarkers Predicting Events in Atherosclerosis
Current Medicinal Chemistry Imaging Techniques as an Aid in the Early Detection of Cardiac Amyloidosis
Current Pharmaceutical Design Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge
Vascular Disease Prevention (Discontinued) Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature
Current Hypertension Reviews Endothelial (Dys)Function in Lone Atrial Fibrillation
Current Pharmaceutical Design Prediction of Degeneration of Native and Bioprosthetic Aortic Valves:Issue-Related Particularities of Diabetes Mellitus
Infectious Disorders - Drug Targets Treatment of Hypertension in Chronic Kidney Disease: Does one Size Fit All? A Narrative Review from a Nephrologist’s Perspective
Current Hypertension Reviews